NCT00573287View on ClinicalTrials.gov

First Episode Schizophrenia and Cannabis-Related Disorder Study

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2011

Conditions
Cannabis-Related DisorderSubstance-Related DisordersSchizophreniaPsychotic Disorders
Interventions
DRUG

clozapine

clozapine--tabs, 450mg. max, daily, 24 weeks

DRUG

risperidone

risperidone--tabs, 6mg max, daily, 24 weeks

Trial Locations (5)

03301

New Hampshire Hospital, Concord

03756

Dartmouth Hitchcock Medical Center, Lebanon

03766

West Central Behavioral Health, Lebanon

03101

Mental Health Center of Greater Manchester, Manchester

03060

Center for Psychiatric Advancement & Community Council of Nashua, Nashua

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00573287 - First Episode Schizophrenia and Cannabis-Related Disorder Study | Biotech Hunter | Biotech Hunter